1/11/2022 | 3004902300 | PLACEBO, S/M, S/M INTRAMUSCULAR, 0MG/ML // PROTOCOL MK1654-004-00 // M#81006566 LOT T036588 - 0001187512 // EXPIRES 28-FEB-2023 SODIUM CHLORIDE 0.9% (0.9G/100ML) , STERILE SOLUTION FOR INJECTION RD 10094-DIGEMID/DPF/EEYS/MINSA, 08-SET-2021,RD 367-2021-OGI | 0.144 | KG | 276.295 | Peru | AMSTERDAM | WORLD COURIER INC | Get Detailed Shipment Records
|
1/10/2022 | 3002419000 | INJECTABLE SUSPENSION, GARDASIL, S/M PHARMACEUTICAL PRODUCT / ACT PRINCIPLE: HUMAN PAPILLOMA VIRUS TYPE 6, 11,16,18 MEDICINE FOR HUMAN USE / ORDER: 6000554517 BOX X1 BOTTLE, LOT: U034657 MFG DATE: 22.05.2021 EXP DATE: 22.05.2024 GARDASIL 0.5ML 1DOSE | 29.932 | KG | 34678.19 | Peru | AMSTERDAM | MERCK SHARP & DOHME INTERNATIONAL |
1/31/2022 | 3004902900 | MEDICATION, MYRBETRIC, S/M CARDBOARD BOX CONTAINING 10 PROLONGED-RELEASE COMMITMENTS LOT: 21D2437; MANF.: 04/2021; EXPIRES: 03/2024 CODE: 142815 // MYRBETRIC TAB 50MG 1x10 PE, MIRABEGRON MEDICATION FOR HUMAN USE // RS: EE-00808 | 5.15 | KG | 26189.171 | Peru | AMSTERDAM | ASTELLAS PHARMA EUROPE B.V. |
1/26/2022 | 3004902400 | XTANDI (ENZALUTAMIDA), S/M, S/M LOT T038164 - 0001227219 // STOCKED LOT PA2095322 // EXPIRES 30-APR-2023 PROTOCOL MK-3475-991 // (81008424) BOTTLE CONTAINING 120 SOFT CAPSULES. ORALLY // 40MG RD 2395-2020-DIGEMID/DPF/AESC/MINSA, 24-APR-2020,RD 117-20 | 5.44 | KG | 271805.166 | Peru | AMSTERDAM | WORLD COURIER INC |
1/25/2022 | 3002419000 | LYOPHILIZED POWDER, ONCOTICE, S/M PHARMACEUTICAL PRODUCT (ONCOLOGICAL PRODUCT) MEDICATION FOR HUMAN USE / ACTIVE PRINCIPLE:BCG, CEPA TICE BOX X 1 VIAL, LOT: U039925, MFG DATE: 06.18.2021 EXP DATE:12.16.2022 ONCOTICE 12.5MG /ML 2ML 1 VIAL PER 1961014,N° P | 8.4 | KG | 11949.085 | Peru | AMSTERDAM | MSDIS OSS PHARMA-OPS |